Novel compound heterozygote mutations in the ATP7B gene in an Iranian family with Wilson disease: A case report

被引:8
作者
Daneshjoo O. [1 ,3 ]
Garshasbi M. [2 ,3 ]
机构
[1] Department of Molecular and Cell Biology, Nano and Biotechnology Research Group, Faculty of Basic Sciences, University of Mazandaran, Babolsar
[2] Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran
[3] Medical Genetics Department, DeNA Laboratory, Tehran
关键词
ATP7B gene; Compound heterozygote; Sequencing; Wilson disease;
D O I
10.1186/s13256-018-1608-0
中图分类号
学科分类号
摘要
Background: Wilson disease is an autosomal recessive disorder of copper transport and is characterized by excessive accumulation of cellular copper in the liver and other tissues because of impaired biliary copper excretion and disturbed incorporation of copper into ceruloplasmin. Hepatic failure and neuronal degeneration are the major symptoms of Wilson disease. Mutations in the ATP7B gene are the major cause of Wilson disease. Case presentation: In this study we have screened one pedigree with several affected members, including a 24-year-old Iranian woman and a 20-year-old Iranian man, who showed psychiatric and neurological symptoms of varying severity, by amplifying the coding regions including exon-intron boundaries with polymerase chain reaction and sequencing. We identified c.1924G>C and c.3809A>G mutations in affected members as compound heterozygote state. These mutations segregated with the disease in the family and they were absent in a cohort of 100 Iranian ethnicity-matched healthy controls. Conclusions: No homozygote state has been reported for these two variants in public databases. In silico predicting tools consider these two variants to be damaging. So this study introduces the novel combination of c.1924G>C and c.3809A>G variants as a cause for Wilson disease. © 2018 The Author(s).
引用
收藏
相关论文
共 23 条
[11]  
Ghaffar T.Y.A., Elsayed S.M., Elnaghy S., Shadeed A., Elsobky E.S., Phenotypic and Genetic Characterization of A Cohort of Pediatric Wilson Disease Patients, (2011)
[12]  
Turnpenny P.D., Ellard S., Emery's Elements of Medical Genetics, (2012)
[13]  
Mameli E., Lepori M.B., Chiappe F., Ranucci G., Di Dato F., Iorio R., Loudianos G., Wilson's disease caused by alternative splicing and Alu exonization due to a homozygous 3039-bp deletion spanning from intron 1 to exon 2 of the ATP7B gene, Gene., 569, 2, pp. 276-279, (2015)
[14]  
Merle U., Weiss K.H., Eisenbach C., Tuma S., Ferenci P., Stremmel W., Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease, BMC Gastroenterol., 10, (2010)
[15]  
Nussbaum R., McInnes R., Willard H.F., Thompson & Thompson Genetics in Medicine, (2016)
[16]  
Thomas G.R., Forbes J.R., Roberts E.A., Walshe J.M., Cox D.W., The Wilson disease gene: Spectrum of mutations and their consequences, Nat Genet., 9, 2, pp. 210-217, (1995)
[17]  
Kalinsky H., Funes A., Zeldin A., Pel-Or Y., Korostishevsky M., Gershoni-Baruch R., Farrer L.A., Bonne-Tamir B., Novel ATP7B mutations causing Wilson disease in several Israeli ethnic groups, Hum Mutat., 11, 2, pp. 145-151, (1998)
[18]  
Lalioti V., Sandoval I., Cassio D., Duclos-Vallee J.C., Molecular pathology of Wilson's disease: A brief, J Hepatol., 53, 6, pp. 1151-1153, (2010)
[19]  
Shah A.B., Chernov I., Zhang H.T., Ross B.M., Das K., Lutsenko S., Parano E., Pavone L., Evgrafov O., Ivanova-Smolenskaya I.A., Anneren G., Westermark K., Urrutia F.H., Penchaszadeh G.K., Sternlieb I., Scheinberg I.H., Gilliam T.C., Petrukhin K., Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses, Am J Hum Genet., 61, 2, pp. 317-328, (1997)
[20]  
Ashkenazy H., Erez E., Martz E., Pupko T., Ben-Tal N., ConSurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids, Nucleic Acids Res., 38, pp. W529-W533, (2010)